Novavax Seeks FDA Authorization for Emergency Use of COVID-19 Vaccine Booster

Novavax Seeks FDA Authorization for Emergency Use of COVID-19 Vaccine Booster
Vials with a sticker reading, "COVID-19 / Coronavirus vaccine / Injection only" and a medical syringe are seen in front of a displayed Novavax logo in this illustration taken Oct. 31, 2020. Dado Ruvic/Illustration/Reuters
Katabella Roberts
Updated:
0:00

Novavax is seeking emergency authorization of its COVID-19 booster shot in adults aged 18 and older from U.S. regulators, the company announced on Monday.

In a press release, the biotechnology company based in Maryland said it has submitted an application to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) for its protein-based booster shot.
Katabella Roberts
Katabella Roberts
Author
Katabella Roberts is a news writer for The Epoch Times, focusing primarily on the United States, world, and business news.
Related Topics